MCCLAIN C HADDOW

LDA lobbyist id 68662. Registrants reported 3 convictions under this id, restated across 34 entries on 34 LD-2 filings.

Disclosed by the registrant on the LD-2, as the Honest Leadership and Open Government Act requires. The text is the registrant's own, reproduced as filed. Open America does not verify it against court records.

Convictions reported under this id

September 15, 1987 Restated on 7 filings

U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts)

As filed by UPSTREAM CONSULTING, INC. for ZIONS THERAPEUTICS, 3rd Quarter 2026 (July 1 - Sep 30). Filing on Open America · Official LD-2 document

September 15, 1987 Restated on 21 filings

9/15/1987, U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts)

As filed by UPSTREAM CONSULTING, INC. for RARE ACCESS ACTION PROJECT, 3rd Quarter 2026 (July 1 - Sep 30). Filing on Open America · Official LD-2 document

September 15, 1987 Restated on 6 filings

18 U.S.C. Section 208(a), conflict of interest (2 counts)

As filed by UPSTREAM CONSULTING, INC. for MANAGEMENT & TRAINING CORPORATION, 3rd Quarter 2026 (July 1 - Sep 30). Filing on Open America · Official LD-2 document

Filings carrying a disclosure under this id 34

Posted	Registrant	Client	Period
Nov 3, 2026	UPSTREAM CONSULTING, INC.	ZIONS THERAPEUTICS	3rd Quarter 2026 (July 1 - Sep 30)	Filing →
Nov 3, 2026	UPSTREAM CONSULTING, INC.	RARE ACCESS ACTION PROJECT	3rd Quarter 2026 (July 1 - Sep 30)	Filing →
Nov 3, 2026	UPSTREAM CONSULTING, INC.	AMERICAN KRATOM ASSOCIATION	3rd Quarter 2026 (July 1 - Sep 30)	Filing →
Nov 3, 2026	UPSTREAM CONSULTING, INC.	MANAGEMENT & TRAINING CORPORATION	3rd Quarter 2026 (July 1 - Sep 30)	Filing →
Jul 17, 2026	UPSTREAM CONSULTING	ZIONS THERAPEUTICS	2nd Quarter 2026 (Apr 1 - June 30)	Filing →
Jul 17, 2026	UPSTREAM CONSULTING	RARE ACCESS ACTION PROJECT	2nd Quarter 2026 (Apr 1 - June 30)	Filing →
Jul 17, 2026	UPSTREAM CONSULTING	PRIMUS PHARMACEUTICAL	2nd Quarter 2026 (Apr 1 - June 30)	Filing →
Jul 17, 2026	UPSTREAM CONSULTING	AMERICAN KRATOM ASSOCIATION	2nd Quarter 2026 (Apr 1 - June 30)	Filing →
Jul 17, 2026	UPSTREAM CONSULTING	MANAGEMENT & TRAINING CORPORATION	2nd Quarter 2026 (Apr 1 - June 30)	Filing →
May 4, 2026	UPSTREAM CONSULTING	ZIONS THERAPEUTICS	1st Quarter 2026 (Jan 1 - Mar 31)	Filing →
May 4, 2026	UPSTREAM CONSULTING	RARE ACCESS ACTION PROJECT	1st Quarter 2026 (Jan 1 - Mar 31)	Filing →
May 4, 2026	UPSTREAM CONSULTING	PRIMUS PHARMACEUTICAL	1st Quarter 2026 (Jan 1 - Mar 31)	Filing →
May 4, 2026	UPSTREAM CONSULTING	AMERICAN KRATOM ASSOCIATION	1st Quarter 2026 (Jan 1 - Mar 31)	Filing →
May 4, 2026	UPSTREAM CONSULTING	MANAGEMENT & TRAINING CORPORATION	1st Quarter 2026 (Jan 1 - Mar 31)	Filing →
Jan 30, 2026	UPSTREAM CONSULTING	ZIONS THERAPEUTICS	4th Quarter 2025 (Oct 1 - Dec 31)	Filing →
Jan 30, 2026	UPSTREAM CONSULTING	RARE ACCESS ACTION PROJECT	4th Quarter 2025 (Oct 1 - Dec 31)	Filing →
Jan 30, 2026	UPSTREAM CONSULTING	PRIMUS PHARMACEUTICAL	4th Quarter 2025 (Oct 1 - Dec 31)	Filing →
Jan 30, 2026	UPSTREAM CONSULTING	AMERICAN KRATOM ASSOCIATION	4th Quarter 2025 (Oct 1 - Dec 31)	Filing →
Jan 30, 2026	UPSTREAM CONSULTING	MANAGEMENT & TRAINING CORPORATION	4th Quarter 2025 (Oct 1 - Dec 31)	Filing →
Oct 25, 2025	UPSTREAM CONSULTING	ZIONS THERAPEUTICS	3rd Quarter 2025 (July 1 - Sep 30)	Filing →
Oct 25, 2025	UPSTREAM CONSULTING	RARE ACCESS ACTION PROJECT	3rd Quarter 2025 (July 1 - Sep 30)	Filing →
Oct 25, 2025	UPSTREAM CONSULTING	PRIMUS PHARMACEUTICAL	3rd Quarter 2025 (July 1 - Sep 30)	Filing →
Oct 25, 2025	UPSTREAM CONSULTING	AMERICAN KRATOM ASSOCIATION	3rd Quarter 2025 (July 1 - Sep 30)	Filing →
Oct 25, 2025	UPSTREAM CONSULTING	MANAGEMENT & TRAINING CORPORATION	3rd Quarter 2025 (July 1 - Sep 30)	Filing →
Aug 1, 2025	UPSTREAM CONSULTING	ZIONS THERAPEUTICS	2nd Quarter 2025 (Apr 1 - June 30)	Filing →

Page 1 of 2 Next

This page covers the conviction disclosures filed under LDA lobbyist id 68662. It is not a full record of the person's lobbying: the lobbyist rows on a filing carry a name but no LDA id, so the two cannot be joined without a change to how the data is stored. Source: federal Lobbying Disclosure Act LD-2 filings.